Compton C - Search Results

1

How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?

Kerwin EM, Jones PW, Bjermer LH, Maltais F, Boucot IH, Naya IP, Lipson DA, Compton C, Tombs L, Vogelmeier CF. Kerwin EM, et al. Among authors: compton c. Chron Respir Dis. 2023 Jan-Dec;20:14799731231202257. doi: 10.1177/14799731231202257. Chron Respir Dis. 2023. PMID: 37800633 Free PMC article. Review.

2

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.

Feldman GJ, Sousa AR, Lipson DA, Tombs L, Barnes N, Riley JH, Patel S, Naya I, Compton C, Alcázar Navarrete B. Feldman GJ, et al. Among authors: compton c. Adv Ther. 2017 Nov;34(11):2518-2533. doi: 10.1007/s12325-017-0626-4. Epub 2017 Nov 1. Adv Ther. 2017. PMID: 29094315 Free PMC article. Clinical Trial.

3

Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials.

Ray R, Tombs L, Asmus MJ, Boucot I, Lipson DA, Compton C, Naya I. Ray R, et al. Among authors: compton c. Drugs Aging. 2018 Jul;35(7):637-647. doi: 10.1007/s40266-018-0558-y. Drugs Aging. 2018. PMID: 29951734 Free PMC article. Clinical Trial.

4

Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β₂-Agonist Therapy: An Integrated Post Hoc Analysis.

Naya IP, Tombs L, Lipson DA, Compton C. Naya IP, et al. Among authors: compton c. Adv Ther. 2018 Oct;35(10):1626-1638. doi: 10.1007/s12325-018-0771-4. Epub 2018 Sep 6. Adv Ther. 2018. PMID: 30191464 Free PMC article.

5

Preventing clinically important deterioration with single-inhaler triple therapy in COPD.

Naya I, Compton C, Ismaila AS, Birk R, Brealey N, Tabberer M, Zhu CQ, Lipson DA, Criner G. Naya I, et al. Among authors: compton c. ERJ Open Res. 2018 Oct 3;4(4):00047-2018. doi: 10.1183/23120541.00047-2018. eCollection 2018 Oct. ERJ Open Res. 2018. PMID: 30302335 Free PMC article.

6

Long-term outcomes following first short-term clinically important deterioration in COPD.

Naya IP, Tombs L, Muellerova H, Compton C, Jones PW. Naya IP, et al. Among authors: compton c. Respir Res. 2018 Nov 20;19(1):222. doi: 10.1186/s12931-018-0928-3. Respir Res. 2018. PMID: 30453972 Free PMC article. Clinical Trial.

7

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis.

Naya I, Tombs L, Lipson DA, Boucot I, Compton C. Naya I, et al. Among authors: compton c. Respir Res. 2019 Mar 26;20(1):60. doi: 10.1186/s12931-019-1027-9. Respir Res. 2019. PMID: 30914064 Free PMC article.

8

Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials.

Ray R, Tombs L, Naya I, Compton C, Lipson DA, Boucot I. Ray R, et al. Among authors: compton c. Pulm Pharmacol Ther. 2019 Aug;57:101802. doi: 10.1016/j.pupt.2019.101802. Epub 2019 May 13. Pulm Pharmacol Ther. 2019. PMID: 31096036 Free article. Clinical Trial.

9

Inhaled corticosteroids, blood eosinophils, and FEV₁ decline in patients with COPD in a large UK primary health care setting.

Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK. Whittaker HR, et al. Among authors: compton ch. Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1063-1073. doi: 10.2147/COPD.S200919. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31213788 Free PMC article.

10

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D. Pascoe S, et al. Among authors: compton c. Lancet Respir Med. 2019 Sep;7(9):745-756. doi: 10.1016/S2213-2600(19)30190-0. Epub 2019 Jul 4. Lancet Respir Med. 2019. PMID: 31281061 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters